What Families Need to Know About First Gene Therapy for Deadly Childhood Cancer – ConsumerReports.org
WBUR |
What Families Need to Know About First Gene Therapy for Deadly Childhood Cancer
ConsumerReports.org An advisory panel to the Food and Drug Administration earlier this week unanimously recommended approving a breakthrough genetic therapy to treat a rare but deadly type of childhood cancer. Here’s why the news has cancer researchers excited—and … FDA Panel Recommends Approval of Novel ‘Gene Therapy‘ for LeukemiaWBUR Novel leukemia treatment could be 1st US gene therapySumter Item FDA Gives A Nod To “Paradigm Shifting” Cancer TreatmentWNPR News BabyCenter (blog) –Medical Daily all 25 news articles » |
KPRC Houston |
How to register to become bone marrow, stem cell donor
KPRC Houston Dr. Simrit Parmar is an associate professor in the department of Stem Cell Transplantation and Cellular Therapy at MD Anderson Cancer Center, Houston. She researches T cells and how they can be used to fight diseases. “If we get a perfect match in the … |
Medical Xpress |
Advance furthers stem cells for use in drug discovery, cell therapy
Medical Xpress Stem cells respond to chemical signals that trigger their development into specialized cells in the brain, muscles and blood vessels. In the lab, researchers use a “substrate” material that anchors the cells in place and allows the necessary signaling … Stem cell-based therapy for targeting skin-to-brain cancerScience Daily Understanding how the intestine replaces and repairs itselfHarvard Gazette Asia-Pacific Stem Cell Market Size, Trends, Share & Forecast to 2022.DailyHover DailyNewsKs all 6 news articles » |
Genetic Engineering & Biotechnology News |
Lung Cancer Immunotherapy Darkens Patients’ Hair
Genetic Engineering & Biotechnology News Patients receiving a specific type of immunotherapy for lung cancer may get an added benefit from the treatment — darker hair. Researchers at Universitat Autònoma de Barcelona in Spain tracked the color of 14 patients’ hair before and during treatment … |
nwitimes.com |
Can Bellicum Pharmaceuticals Stock Bounce Back?
nwitimes.com Why did this bad news for another biotech hurt Bellicum? It’s using the same basic technology as Juno — chimeric antigen receptor T–cell (CAR-T) therapy. With CAR-T therapies, patients’ T–cells (white blood cells produced in the thymus gland that are … |